| pubmed-article:7799020 | pubmed:abstractText | The antitumor effect of etoposide is increased by maintaining a low blood level, whereas high peak levels may cause myelotoxicity. We investigated whether a constant low blood level could be obtained by the administration of oral etoposide three times daily. | lld:pubmed |
